ADMET technologies determine properties of a drug candidate in the preclinical stage of discovery. Poor ADMET properties are a major cause for a candidate to fail in development. ADMET describes the process of absorption, distribution, metabolism, excretion and toxicity of a new drug in the body. This meeting will discuss technologies that enable developers to predict ADMET properties and increase the success rate of new compounds.
